[1]
Razmjoo, S. et al. 2024. Real-World Clinical Outcomes of Low Dose versus Standard Dose Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Prospective Pragmatic Study. Asian Pacific Journal of Cancer Biology. 9, 4 (Oct. 2024), 447–454. DOI:https://doi.org/10.31557/apjcb.2024.9.4.447-454.